INT262902

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.02
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.88
Pain Relevance 0.40

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (FGF7) extracellular space (FGF7) extracellular region (FGF7)
Golgi apparatus (FGF7)
FGF7 (Homo sapiens)
Pain Link Frequency Relevance Heat
cytokine 13 89.76 High High
Inflammation 13 84.32 Quite High
Analgesic 1 70.68 Quite High
Piles 1 63.48 Quite High
methotrexate 2 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
abdominal pain 1 5.00 Very Low Very Low Very Low
psoriasis 1 5.00 Very Low Very Low Very Low
nud 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Mucositis 55 96.16 Very High Very High Very High
Injury 20 96.12 Very High Very High Very High
INFLAMMATION 13 84.32 Quite High
Apoptosis 6 64.56 Quite High
Anorectal Disorders 1 63.48 Quite High
Stomatitis 4 40.96 Quite Low
Toxicity 16 5.00 Very Low Very Low Very Low
Canker Sores 6 5.00 Very Low Very Low Very Low
Cancer 5 5.00 Very Low Very Low Very Low
Ulcers 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Still, Palifermin

(recombinant human KGF-1) remains the only agent currently approved by the FDA for

Regulation (approved) of KGF-1 Binding (agent) of
1) Confidence 0.02 Published 2008 Journal Journal of Oncology Section Body Doc Link PMC2648637 Disease Relevance 0.88 Pain Relevance 0.40

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox